Gut mucosal microbiome across stages of colorectal carcinogenesis

Geicho Nakatsu, Xiangchun Li, Haokui Zhou, Jianqiu Sheng, Sunny Hei Wong, William Ka Kai Wu, Siew Chien Ng, Ho Tsoi, Yujuan Dong, Ning Zhang, Yuqi He, Qian Kang, Lei Cao, Kunning Wang, Jingwan Zhang, Qiaoyi Liang, Jun Yu, Joseph J Y Sung, Geicho Nakatsu, Xiangchun Li, Haokui Zhou, Jianqiu Sheng, Sunny Hei Wong, William Ka Kai Wu, Siew Chien Ng, Ho Tsoi, Yujuan Dong, Ning Zhang, Yuqi He, Qian Kang, Lei Cao, Kunning Wang, Jingwan Zhang, Qiaoyi Liang, Jun Yu, Joseph J Y Sung

Abstract

Gut microbial dysbiosis contributes to the development of colorectal cancer (CRC). Here we catalogue the microbial communities in human gut mucosae at different stages of colorectal tumorigenesis. We analyse the gut mucosal microbiome of 47 paired samples of adenoma and adenoma-adjacent mucosae, 52 paired samples of carcinoma and carcinoma-adjacent mucosae and 61 healthy controls. Probabilistic partitioning of relative abundance profiles reveals that a metacommunity predominated by members of the oral microbiome is primarily associated with CRC. Analysis of paired samples shows differences in community configurations between lesions and the adjacent mucosae. Correlations of bacterial taxa indicate early signs of dysbiosis in adenoma, and co-exclusive relationships are subsequently more common in cancer. We validate these alterations in CRC-associated microbiome by comparison with two previously published data sets. Our results suggest that a taxonomically defined microbial consortium is implicated in the development of CRC.

Figures

Figure 1. Characterization of 16S rRNA gene…
Figure 1. Characterization of 16S rRNA gene catalogue for mucosal microbial communities in colorectal carcinogenesis.
Fitting microbiome data to DMM models defined five metacommunities. Reads that are considered as being potentially originated from oral strains or known pathogenic strains in the human gut were classified against the 16S rRNA gene collections from the Human Oral Microbiome (HOM; version 13) database and PATRIC bacterial pathogen database as defined by pseudo-bootstrapped (n=1,000) confidence scores of 100 at species-level taxa or deeper, using the naive Bayesian classifier. The panels of metacommunity markers are ranked in the descending order of linear discriminant analysis scores from top to bottom. Columns represent microbiome profiles (arcsine square root-transformed) of 269 mucosal biopsies from individuals with or without adenoma or adenocarcinomas. (MCPI<0 for changes characteristic of adenomas; MCPI>0 for changes characteristic of carcinomas).
Figure 2. Validations of metacommunity markers in…
Figure 2. Validations of metacommunity markers in independent cohorts.
(a,b) Fold-change analyses in paired carcinoma and carcinoma-adjacent samples in two additional cohorts demonstrated significant agreement with our discovery cohort: (a) Kostic et al. data set (n=74) and (b) Zeller et al. data set (n=48). Shown are adjusted R2 and P values for goodness of fit from multiple linear regression models. (c) Real-time PCR amplifications of the most abundant sequences of representative bacterial phylotypes showed consistent enrichments in an additional Chinese cohort consisting of 207 mucosal biopsies (normal control, n=25; adenoma, n=41; adenocarcinoma, n=50). Error bars represent s.e.m. P values from Mann–Whitney U-tests are adjusted by Benjamini-Hochberg (BH) step-up procedure; *q<0.05; **q<0.01; ***q<0.001; ****q<0.0001.
Figure 3. Community-wide alterations of microbiome profiles…
Figure 3. Community-wide alterations of microbiome profiles are important aspects of multistage colorectal tumour progression.
(a) Discordance of taxonomic configurations between lesions and lesion-adjacent tissues was significantly associated with the metacommunities identified within carcinoma. Shown are mean P values from 1,000 iterations of Fisher's exact tests with Monte Carlo simulation (10,000 replicates). (b) Percentages of change between metacommunities from lesion-adjacent mucosae to lesions within each clinicopathologic stage of tumours. LGDP, colorectal polyps with low-grade dysplasia (n=39); HGDP, colorectal polyps with high-grade dysplasia (n=13); ECRC, early-stage CRC (n=26); LCRC, late-stage CRC (n=26). (c) Significances of fold change in metacommunity markers, as estimated by paired Mann–Whitney U-tests, were greatest at early-stage CRC.
Figure 4. Microbial community ecology at mucosal…
Figure 4. Microbial community ecology at mucosal interface are different across stages of colorectal carcinogenesis.
(a–c) Correlation network of taxonomic partners in: (a) normal (n=61), (b) adenomatous polyps (n=52) and (c) cancerous mucosae (n=52). Correlation coefficients were estimated and corrected for compositional effects using the SparCC algorithm. A subset of correlations with strengths of at least 0.3 was selected for visualization. Node size represents mean taxon abundance in each mucosal phenotype; metacommunity markers are denoted by node numbers accordingly. Taxa that are classified as members of the same bacterial phylum are encircled by dashed lines.

References

    1. Sears C. L. & Garrett W. S. Microbes, microbiota, and colon cancer. Cell Host Microbe 15, 317–328 (2014).
    1. Zackular J. P., Rogers M. A., Ruffin M. T. 4th & Schloss P. D. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev. Res. 7, 1112–1121 (2014).
    1. Irrazabal T., Belcheva A., Girardin S. E., Martin A. & Philpott D. J. The multifaceted role of the intestinal microbiota in colon cancer. Mol. Cell 54, 309–320 (2014).
    1. Belcheva A. et al. Gut microbial metabolism drives transformation of Msh2-deficient colon epithelial cells. Cell 158, 288–299 (2014).
    1. Ijssennagger N. et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc. Natl Acad. Sci. USA 112, 10038–10043 (2015).
    1. Rubinstein M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195–206 (2013).
    1. Kostic A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292–298 (2012).
    1. Castellarin M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299–306 (2012).
    1. Tahara T. et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 74, 1311–1318 (2014).
    1. Mima K. et al. Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol. 1, 653–661 (2015).
    1. Gur C. et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42, 382–392 (2015).
    1. Warren R. L. et al. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 1, 16 (2013).
    1. Geng J., Fan H., Tang X., Zhai H. & Zhang Z. Diversified pattern of the human colorectal cancer microbiome. Gut. Pathog. 5, 2 (2013).
    1. Chen W., Liu F., Ling Z., Tong X. & Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE 7, e39743 (2012).
    1. Ding T. & Schloss P. D. Dynamics and associations of microbial community types across the human body. Nature 509, 357–360 (2014).
    1. Schloss P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537–7541 (2009).
    1. Schloss P. D., Gevers D. & Westcott S. L. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS ONE 6, e27310 (2011).
    1. Holmes I., Harris K. & Quince C. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS ONE 7, e30126 (2012).
    1. Breiman L. Random Forests. Mach. Learn. 45, 5–32 (2001).
    1. Zeller G. et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol. 10, 766 (2014).
    1. Tibshirani R. Regression selection and shrinkage via the lasso. J. Royal Stat. Soc. B 58, 267–288 (1994).
    1. Friedman J. & Alm E. J. Inferring correlation networks from genomic survey data. PLoS Comput. Biol. 8, e1002687 (2012).
    1. Boleij A. et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60, 208–215 (2015).
    1. Dejea C. M. et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl Acad. Sci. USA 111, 18321–18326 (2014).
    1. Johnson C. H. et al. Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab. 21, 891–897 (2015).
    1. Liu J. et al. Metabolic co-dependence gives rise to collective oscillations within biofilms. Nature 523, 550–554 (2015).
    1. Gnagnarellla P., Gandini S., La Vecchia C. & Maisonneuve P. Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am. J. Clin. Nutr. 87, 1793–1801 (2008).
    1. Meyerhardt J. A. et al. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J. Natl Cancer Inst. 104, 1702–1711 (2012).
    1. Arthur J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120–123 (2012).
    1. Grivennikov S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254–258 (2012).
    1. Huber S. et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491, 259–263 (2012).
    1. Couturier-Maillard A. et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123, 700–711 (2013).
    1. Cuevas-Ramos G. et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl Acad. Sci. USA 107, 11537–11542 (2010).
    1. Riley D. R. et al. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Comput. Biol. 9, e1003107 (2013).
    1. Maurice C. F., Haiser H. J. & Turnbaugh P. J. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152, 39–50 (2013).
    1. Shah P. & Swiatlo E. A multifaceted role for polyamines in bacterial pathogens. Mol. Microbiol. 68, 4–16 (2008).
    1. Murray I. A., Patterson A. D. & Perdew G. H. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat. Rev. Cancer. 14, 801–814 (2014).
    1. Royet J., Gupta D. & Dziarski R. Peptidoglycan recognition proteins: modulators of the microbiome and inflammation. Nat. Rev. Immunol. 11, 837–851 (2011).
    1. Wu S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med 15, 1016–1022 (2009).
    1. Farrell J. J. et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 61, 582–588 (2012).
    1. Harrell L. et al. Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon. PLoS ONE 7, e32545 (2012).
    1. Wong M. C. et al. A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese. Aliment. Pharmacol. Ther. 32, 74–82 (2010).
    1. Wong M. C. et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut. 63, 1130–1136 (2014).
    1. Yeoh K.-G. et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 60, 1236–1241 (2011).
    1. Yuan S., Cohen D. B., Ravel J., Abdo Z. & Forney L. J. Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS ONE 7, e33865 (2012).
    1. Quince C., Lanzen A., Davenport R. J. & Turnbaugh P. J. Removing noise from pyrosequenced amplicons. BMC Bioinformatics 12, 38 (2011).
    1. Schloss P. D. A high-throughput DNA sequence aligner for microbial ecology studies. PLoS ONE 4, e8230 (2009).
    1. Edgar R. C., Haas B. J., Clemente J. C., Quince C. & Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194–2200 (2011).
    1. Wang Q., Garrity G. M., Tiedje J. M. & Cole J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261–5267 (2007).
    1. Koren O. et al. A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput. Biol. 9, e1002863 (2013).
    1. Gobet A., Quince C. & Ramette A. Multivariate cutoff level analysis (MultiCoLA) of large community data sets. Nucleic Acids Res. 38, e155 (2010).
    1. Langille M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814–821 (2013).
    1. Abubucker S. et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol. 8, e1002358 (2012).
    1. Gevers D. et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382–392 (2014).
    1. Segata N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
    1. Smialowski P., Frishman D. & Kramer S. Pitfalls of supervised feature selection. Bioinformatics 26, 440–443 (2009).

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться